Dawson C A, Linehan J H, Rickaby D A, Bronikowski T A
Ann Biomed Eng. 1987;15(2):217-27. doi: 10.1007/BF02364056.
The pulmonary endothelium is capable of removing and metabolizing serotonin (5HT) carried in the venous blood. Thus the lungs can influence the arterial concentrations of 5HT. In addition, there is evidence that changes in the lung uptake of 5HT might portend more serious endothelial damage wherein the barrier function of the endothelium is compromised. This has been a stimulus for finding methods for evaluating these endothelial functions. These methods must be able to distinguish changes in whole organ function which result from changes in perfusion (e.g., cardiac output, redistribution of flow, etc.) from those resulting from changes in the function of the endothelial cells. When a bolus containing radio-labeled 5HT and an unmetabolizable indicator which is confined to the vascular space is injected into the pulmonary artery, the pulmonary venous or systemic arterial concentration curves contain information about both the convective transport and endothelial cell process involved. Some of this information can be interpreted quantitatively using a simple mathematical model.
肺内皮细胞能够清除和代谢静脉血中携带的血清素(5-羟色胺,5HT)。因此,肺脏能够影响5HT的动脉血浓度。此外,有证据表明,肺对5HT摄取的变化可能预示着更严重的内皮损伤,即内皮细胞的屏障功能受到损害。这促使人们寻找评估这些内皮功能的方法。这些方法必须能够区分因灌注变化(如心输出量、血流重新分布等)导致的全器官功能变化与因内皮细胞功能变化导致的全器官功能变化。当将含有放射性标记的5HT和一种局限于血管腔内的不可代谢指示剂的团注物注入肺动脉时,肺静脉或体动脉浓度曲线包含了有关对流运输和内皮细胞过程的信息。其中一些信息可以使用一个简单的数学模型进行定量解释。